Ferenc Gallyas - Publications

Neurosurgery  University of Pécs, Hungary, Pécs, Hungary 

84 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gallyas F, Sumegi B. Mitochondrial Protection by PARP Inhibition. International Journal of Molecular Sciences. 21. PMID 32316192 DOI: 10.3390/Ijms21082767  0.33
2020 Gallyas F, Sumegi B, Szabo C. Role of Akt Activation in PARP Inhibitor Resistance in Cancer. Cancers. 12. PMID 32106627 DOI: 10.3390/Cancers12030532  0.323
2019 Svab G, Doczi J, Gerencser AA, Ambrus A, Gallyas F, Sümegi B, Tretter L. The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria. Neurochemical Research. PMID 31535355 DOI: 10.1007/S11064-019-02871-9  0.34
2019 Cseh AM, Fabian Z, Quintana-Cabrera R, Szabo A, Eros K, Soriano ME, Gallyas F, Scorrano L, Sumegi B. PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells. Frontiers in Physiology. 10: 538. PMID 31133874 DOI: 10.3389/Fphys.2019.00538  0.339
2019 Kovacs K, Vaczy A, Fekete K, Kovari P, Atlasz T, Reglodi D, Gabriel R, Gallyas F, Sumegi B. PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB. Investigative Ophthalmology & Visual Science. 60: 1478-1490. PMID 30973576 DOI: 10.1167/Iovs.18-25936  0.307
2018 Tapodi A, Bognár Z, Szabo C, Gallyas F, Sümegi B, Hocsák E. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochemical Pharmacology. PMID 30296409 DOI: 10.1016/J.Bcp.2018.10.005  0.368
2018 Szabo A, Sumegi K, Fekete K, Hocsak E, Debreceni B, Setalo G, Kovacs K, Deres L, Kengyel A, Kovacs D, Mandl J, Nyitrai M, Febbraio MA, Gallyas F, Sumegi B. Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases. Biochemical Pharmacology. PMID 29378182 DOI: 10.1016/J.Bcp.2018.01.038  0.326
2017 Bognar Z, Fekete K, Antus C, Hocsak E, Bognar R, Tapodi A, Boronkai A, Farkas N, Gallyas F, Sumegi B, Szanto A. Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways. Plos One. 12: e0189470. PMID 29220397 DOI: 10.1371/Journal.Pone.0189470  0.349
2017 Hocsak E, Szabo V, Kalman N, Antus C, Cseh A, Sumegi K, Eros K, Hegedus Z, Gallyas F, Sumegi B, Racz B. PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway. Free Radical Biology & Medicine. PMID 28457938 DOI: 10.1016/J.Freeradbiomed.2017.04.018  0.384
2017 Eros K, Magyar K, Deres L, Skazel A, Riba A, Vamos Z, Kalai T, Gallyas F, Sumegi B, Toth K, Halmosi R. Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. Plos One. 12: e0174401. PMID 28339485 DOI: 10.1371/Journal.Pone.0174401  0.337
2017 Sumegi K, Fekete K, Antus C, Debreceni B, Hocsak E, Gallyas F, Sumegi B, Szabo A. BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species. Plos One. 12: e0169372. PMID 28046125 DOI: 10.1371/Journal.Pone.0169372  0.339
2015 Solti I, Kvell K, Talaber G, Veto S, Acs P, Gallyas F, Illes Z, Fekete K, Zalan P, Szanto A, Bognar Z. Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis. Plos One. 10: e0129217. PMID 26053248 DOI: 10.1371/Journal.Pone.0129217  0.311
2015 Turi Z, Hocsak E, Racz B, Szabo A, Balogh A, Sumegi B, Gallyas F. Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancy. Journal of Cancer. 6: 470-6. PMID 25874011 DOI: 10.7150/Jca.11494  0.383
2015 Priber J, Fonai F, Jakus PB, Racz B, Chinopoulos C, Tretter L, Gallyas F, Sumegi B, Veres B. Cyclophilin D disruption attenuates lipopolysaccharide-induced inflammatory response in primary mouse macrophages. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 93: 241-50. PMID 25728038 DOI: 10.1139/Bcb-2014-0120  0.32
2014 Kiss T, Kovacs K, Komocsi A, Tornyos A, Zalan P, Sumegi B, Gallyas F, Kovacs K. Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt. Plos One. 9: e104890. PMID 25133539 DOI: 10.1371/Journal.Pone.0104890  0.312
2014 Deres L, Bartha E, Palfi A, Eros K, Riba A, Lantos J, Kalai T, Hideg K, Sumegi B, Gallyas F, Toth K, Halmosi R. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms. Plos One. 9: e102148. PMID 25014216 DOI: 10.1371/Journal.Pone.0102148  0.309
2014 Magyar K, Deres L, Eros K, Bruszt K, Seress L, Hamar J, Hideg K, Balogh A, Gallyas F, Sumegi B, Toth K, Halmosi R. A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats. Biochimica Et Biophysica Acta. 1842: 935-44. PMID 24657811 DOI: 10.1016/J.Bbadis.2014.03.008  0.302
2013 Kalmar-Nagy K, Degrell P, Szabo A, Sumegi K, Wittmann I, Gallyas F, Sumegi B. PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade. Plos One. 8: e81928. PMID 24312605 DOI: 10.1371/Journal.Pone.0081928  0.344
2013 Bognar E, Sarszegi Z, Szabo A, Debreceni B, Kalman N, Tucsek Z, Sumegi B, Gallyas F. Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol. Plos One. 8: e65355. PMID 23755222 DOI: 10.1371/Journal.Pone.0065355  0.34
2013 Jakus PB, Kalman N, Antus C, Radnai B, Tucsek Z, Gallyas F, Sumegi B, Veres B. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. The Journal of Nutritional Biochemistry. 24: 819-23. PMID 22925919 DOI: 10.1016/J.Jnutbio.2012.04.017  0.316
2012 Radnai B, Antus C, Racz B, Engelmann P, Priber JK, Tucsek Z, Veres B, Turi Z, Lorand T, Sumegi B, Gallyas F. Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation. Molecular Cancer. 11: 34. PMID 22583868 DOI: 10.1186/1476-4598-11-34  0.357
2012 Sarszegi Z, Bognar E, Gaszner B, Kónyi A, Gallyas F, Sumegi B, Berente Z. BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases. Molecular and Cellular Biochemistry. 365: 129-37. PMID 22350755 DOI: 10.1007/S11010-012-1252-8  0.34
2011 Szabo A, Balog M, Mark L, Montsko G, Turi Z, Gallyas F, Sumegi B, Kalai T, Hideg K, Kovacs K. Induction of mitochondrial destabilization and necrotic cell death by apolar mitochondria-directed SOD mimetics. Mitochondrion. 11: 476-87. PMID 21292036 DOI: 10.1016/J.Mito.2011.01.006  0.36
2010 Racz B, Hanto K, Tapodi A, Solti I, Kalman N, Jakus P, Kovacs K, Debreceni B, Gallyas F, Sumegi B. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation. Free Radical Biology & Medicine. 49: 1978-88. PMID 20920579 DOI: 10.1016/J.Freeradbiomed.2010.09.026  0.355
2010 Hocsak E, Racz B, Szabo A, Pozsgai E, Szigeti A, Szigeti E, Gallyas F, Sumegi B, Javor S, Bellyei S. TIP47 confers resistance to taxol-induced cell death by preventing the nuclear translocation of AIF and Endonuclease G. European Journal of Cell Biology. 89: 853-61. PMID 20708296 DOI: 10.1016/J.Ejcb.2010.06.010  0.359
2010 Atlasz T, Szabadfi K, Kiss P, Racz B, Gallyas F, Tamas A, Gaal V, Marton Z, Gabriel R, Reglodi D. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Annals of the New York Academy of Sciences. 1200: 128-39. PMID 20633141 DOI: 10.1111/J.1749-6632.2010.05512.X  0.32
2010 Hocsak E, Racz B, Szabo A, Mester L, Rapolti E, Pozsgai E, Javor S, Bellyei S, Gallyas F, Sumegi B, Szigeti A. TIP47 protects mitochondrial membrane integrity and inhibits oxidative-stress-induced cell death. Febs Letters. 584: 2953-60. PMID 20556887 DOI: 10.1016/J.Febslet.2010.05.027  0.351
2010 Horvath G, Racz B, Reglodi D, Kovacs K, Kiss P, Gallyas F, Bognar Z, Szabo A, Magyarlaki T, Laszlo E, Lubics A, Tamas A, Toth G, Szakaly P. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion. Journal of Molecular Neuroscience : Mn. 42: 411-8. PMID 20229361 DOI: 10.1007/S12031-010-9342-0  0.346
2010 Veto S, Acs P, Bauer J, Lassmann H, Berente Z, Setalo G, Borgulya G, Sumegi B, Komoly S, Gallyas F, Illes Z. Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain : a Journal of Neurology. 133: 822-34. PMID 20157013 DOI: 10.1093/Brain/Awp337  0.363
2010 Racz B, Horvath G, Reglodi D, Gasz B, Kiss P, Gallyas F, Sumegi B, Toth G, Nemeth A, Lubics A, Tamas A. PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Regulatory Peptides. 160: 91-8. PMID 19969027 DOI: 10.1016/J.Regpep.2009.12.003  0.362
2010 Szigeti A, Hocsak E, Rapolti E, Racz B, Boronkai A, Pozsgai E, Debreceni B, Bognar Z, Bellyei S, Sumegi B, Gallyas F. Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein. The Journal of Biological Chemistry. 285: 2140-51. PMID 19901022 DOI: 10.1074/Jbc.M109.015222  0.354
2009 Boronkai A, Bellyei S, Szigeti A, Pozsgai E, Bognar Z, Sumegi B, Gallyas F. Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. European Journal of Cell Biology. 88: 753-63. PMID 19717209 DOI: 10.1016/J.Ejcb.2009.07.005  0.364
2009 Mester L, Szabo A, Atlasz T, Szabadfi K, Reglodi D, Kiss P, Racz B, Tamas A, Gallyas F, Sumegi B, Hocsak E, Gabriel R, Kovacs K. Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotoxicity Research. 16: 68-76. PMID 19526300 DOI: 10.1007/S12640-009-9049-6  0.382
2009 Szanto A, Hellebrand EE, Bognar Z, Tucsek Z, Szabo A, Gallyas F, Sumegi B, Varbiro G. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochemical Pharmacology. 77: 1348-57. PMID 19426673 DOI: 10.1016/J.Bcp.2009.01.008  0.352
2009 Gallyas F, Pál J, Bukovics P. Supravital microwave experiments support that the formation of "dark" neurons is propelled by phase transition in an intracellular gel system. Brain Research. 1270: 152-6. PMID 19324025 DOI: 10.1016/J.Brainres.2009.03.020  0.349
2009 Kovacs K, Hanto K, Bognar Z, Tapodi A, Bognar E, Kiss GN, Szabo A, Rappai G, Kiss T, Sumegi B, Gallyas F. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers. Molecular and Cellular Biochemistry. 321: 155-64. PMID 18975057 DOI: 10.1007/S11010-008-9929-8  0.323
2008 Gallyas F, Kiglics V, Baracskay P, Juhász G, Czurkó A. The mode of death of epilepsy-induced "dark" neurons is neither necrosis nor apoptosis: an electron-microscopic study. Brain Research. 1239: 207-15. PMID 18801347 DOI: 10.1016/J.Brainres.2008.08.069  0.393
2008 Bukovics P, Pál J, Gallyas F. Aldehyde fixation is not necessary for the formation of "dark" neurons. Acta Neuropathologica. 116: 463-4. PMID 18696090 DOI: 10.1007/S00401-008-0424-9  0.38
2008 Racz B, Horvath G, Faluhelyi N, Nagy AD, Tamas A, Kiss P, Gallyas F, Toth G, Gaszner B, Csernus V, Reglodi D. Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes. Journal of Molecular Neuroscience : Mn. 36: 220-6. PMID 18592414 DOI: 10.1007/S12031-008-9112-4  0.305
2008 Rácz B, Gasz B, Gallyas F, Kiss P, Tamás A, Szántó Z, Lubics A, Lengvári I, Tóth G, Hegyi O, Roth E, Reglodi D. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regulatory Peptides. 145: 105-15. PMID 17981349 DOI: 10.1016/j.regpep.2007.09.015  0.301
2007 Rácz B, Gallyas F, Kiss P, Tamás A, Lubics A, Lengvári I, Röth E, Tóth G, Hegyi O, Verzál Z, Fabricsek C, Reglódi D. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats. Neurotoxicity Research. 12: 95-104. PMID 17967733 DOI: 10.1007/Bf03033918  0.381
2007 Racz B, Reglodi D, Fodor B, Gasz B, Lubics A, Gallyas F, Roth E, Borsiczky B. Hyperosmotic stress-induced apoptotic signaling pathways in chondrocytes. Bone. 40: 1536-43. PMID 17392049 DOI: 10.1016/J.Bone.2007.02.011  0.351
2007 Kovács B, Bukovics P, Gallyas F. Morphological effects of transcardially perfused SDS on the rat brain. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 99: 425-32. PMID 17371297 DOI: 10.1042/Bc20060128  0.383
2007 Kövesdi E, Pál J, Gallyas F. The fate of "dark" neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: neurobiological aspects. Brain Research. 1147: 272-83. PMID 17349980 DOI: 10.1016/J.Brainres.2007.02.011  0.384
2007 Bellyei S, Szigeti A, Pozsgai E, Boronkai A, Gomori E, Hocsak E, Farkas R, Sumegi B, Gallyas F. Preventing apoptotic cell death by a novel small heat shock protein. European Journal of Cell Biology. 86: 161-71. PMID 17275951 DOI: 10.1016/J.Ejcb.2006.12.004  0.317
2007 Bellyei S, Szigeti A, Boronkai A, Pozsgai E, Gomori E, Melegh B, Janaky T, Bognar Z, Hocsak E, Sumegi B, Gallyas F. Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway. Apoptosis : An International Journal On Programmed Cell Death. 12: 97-112. PMID 17136496 DOI: 10.1007/S10495-006-0486-X  0.338
2006 Szigeti A, Bellyei S, Gasz B, Boronkai A, Hocsak E, Minik O, Bognar Z, Varbiro G, Sumegi B, Gallyas F. Induction of necrotic cell death and mitochondrial permeabilization by heme binding protein 2/SOUL. Febs Letters. 580: 6447-54. PMID 17098234 DOI: 10.1016/J.Febslet.2006.10.067  0.342
2006 Rácz B, Gallyas F, Kiss P, Tóth G, Hegyi O, Gasz B, Borsiczky B, Ferencz A, Roth E, Tamás A, Lengvári I, Lubics A, Reglodi D. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways. Regulatory Peptides. 137: 20-6. PMID 16945433 DOI: 10.1016/J.Regpep.2006.02.009  0.363
2006 Bognar Z, Kalai T, Palfi A, Hanto K, Bognar B, Mark L, Szabo Z, Tapodi A, Radnai B, Sarszegi Z, Szanto A, Gallyas F, Hideg K, Sumegi B, Varbiro G. A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. Free Radical Biology & Medicine. 41: 835-48. PMID 16895804 DOI: 10.1016/J.Freeradbiomed.2006.06.004  0.378
2006 Rácz B, Tamás A, Kiss P, Tóth G, Gasz B, Borsiczky B, Ferencz A, Gallyas F, Roth E, Reglodi D. Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion. Annals of the New York Academy of Sciences. 1070: 507-11. PMID 16891269 DOI: 10.1196/Annals.1317.070  0.325
2006 Gasz B, Rácz B, Röth E, Borsiczky B, Tamás A, Boronkai A, Gallyas F, Tóth G, Reglodi D. PACAP inhibits oxidative stress-induced activation of MAP kinase-dependent apoptotic pathway in cultured cardiomyocytes. Annals of the New York Academy of Sciences. 1070: 293-7. PMID 16891268 DOI: 10.1196/Annals.1317.029  0.36
2006 Gallyas F, Gasz B, Szigeti A, Mázló M. Pathological circumstances impair the ability of "dark" neurons to undergo spontaneous recovery. Brain Research. 1110: 211-20. PMID 16872583 DOI: 10.1016/J.Brainres.2006.06.078  0.361
2006 Palfi A, Toth A, Hanto K, Deres P, Szabados E, Szereday Z, Kulcsar G, Kalai T, Hideg K, Gallyas F, Sumegi B, Toth K, Halmosi R. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. Journal of Molecular and Cellular Cardiology. 41: 149-59. PMID 16716347 DOI: 10.1016/J.Yjmcc.2006.03.427  0.305
2006 Kellermayer R, Zsombok A, Auer T, Gallyas F. Electrically induced gel-to-gel phase-transition in neurons. Cell Biology International. 30: 175-82. PMID 16376580 DOI: 10.1016/J.Cellbi.2005.11.002  0.339
2006 Kovacs K, Toth A, Deres P, Kalai T, Hideg K, Gallyas F, Sumegi B. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochemical Pharmacology. 71: 441-52. PMID 16337154 DOI: 10.1016/J.Bcp.2005.05.036  0.334
2005 Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, Gallyas F, Varbiro G, Sumegi B. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. The Journal of Biological Chemistry. 280: 35767-75. PMID 16115861 DOI: 10.1074/Jbc.M507075200  0.375
2005 Zsombok A, Tóth Z, Gallyas F. Basophilia, acidophilia and argyrophilia of "dark" (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment. Journal of Neuroscience Methods. 142: 145-52. PMID 15652628 DOI: 10.1016/J.Jneumeth.2004.08.005  0.372
2005 Gallyas F, Csordás A, Schwarcz A, Mázló M. "Dark" (compacted) neurons may not die through the necrotic pathway. Experimental Brain Research. 160: 473-86. PMID 15480602 DOI: 10.1007/S00221-004-2037-4  0.386
2004 Mázló M, Gasz B, Szigeti A, Zsombok A, Gallyas F. Debris of "dark" (compacted) neurones are removed from an otherwise undamaged environment mainly by astrocytes via blood vessels. Journal of Neurocytology. 33: 557-67. PMID 15906162 DOI: 10.1007/S11068-004-0517-5  0.367
2004 Gallyas F, Farkas O, Mázló M. Gel-to-gel phase transition may occur in mammalian cells: Mechanism of formation of "dark" (compacted) neurons. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 313-24. PMID 15145535 DOI: 10.1016/J.Biolcel.2004.01.009  0.372
2004 Veres B, Radnai B, Gallyas F, Varbiro G, Berente Z, Osz E, Sumegi B. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. The Journal of Pharmacology and Experimental Therapeutics. 310: 247-55. PMID 14999056 DOI: 10.1124/Jpet.104.065151  0.323
2003 Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, Gallyas F. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. The Journal of Pharmacology and Experimental Therapeutics. 307: 615-25. PMID 12970391 DOI: 10.1124/Jpet.103.053553  0.329
2003 Veres B, Gallyas F, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochemical Pharmacology. 65: 1373-82. PMID 12694878 DOI: 10.1016/S0006-2952(03)00077-7  0.322
2003 Csordás A, Mázló M, Gallyas F. Recovery versus death of "dark" (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations. Acta Neuropathologica. 106: 37-49. PMID 12665989 DOI: 10.1007/S00401-003-0694-1  0.388
2003 Varbiro G, Toth A, Tapodi A, Veres B, Sumegi B, Gallyas F. Concentration dependent mitochondrial effect of amiodarone. Biochemical Pharmacology. 65: 1115-28. PMID 12663047 DOI: 10.1016/S0006-2952(02)01660-X  0.32
2002 Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, et al. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine. 30: 1071-82. PMID 12006805 DOI: 10.1097/00003246-200205000-00019  0.316
2002 Racz I, Tory K, Gallyas F, Berente Z, Osz E, Jaszlits L, Bernath S, Sumegi B, Rabloczky G, Literati-Nagy P. BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity. Biochemical Pharmacology. 63: 1099-111. PMID 11931842 DOI: 10.1016/S0006-2952(01)00935-2  0.334
2001 Varbiro G, Veres B, Gallyas F, Sumegi B. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radical Biology & Medicine. 31: 548-58. PMID 11498288 DOI: 10.1016/S0891-5849(01)00616-5  0.339
2001 Seress L, Abrahám H, Paleszter M, Gallyas F. Granule cells are the main source of excitatory input to a subpopulation of GABAergic hippocampal neurons as revealed by electron microscopic double staining for zinc histochemistry and parvalbumin immunocytochemistry. Experimental Brain Research. 136: 456-62. PMID 11291726 DOI: 10.1007/S002210000601  0.322
2001 Seress L, Ábrahám H, Paleszter M, Gallyas F. Erratum: Granule cells are the main source of excitatory input to a subpopulation of GABAergic hippocampal neurons as revealed by electron microscopic double staining for zinc histochemistry and parvalbumin immunocytochemistry (Experimental Brain Research (2001) 136 (456-462)) Experimental Brain Research. 137. DOI: 10.1007/S002210100714  0.325
1999 Szabados E, Fischer GM, Gallyas F, Kispal G, Sumegi B. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Radical Biology & Medicine. 27: 1103-13. PMID 10569643 DOI: 10.1016/S0891-5849(99)00151-3  0.325
1996 Horváth Z, Hsu M, Pierre E, Vadi D, Gallyas F, Buzsáki G. Structural impairment of hippocampal neurons following a single epileptic afterdischarge. Epilepsy Research. Supplement. 12: 325-34. PMID 9302532  0.557
1994 Hsu M, Sik A, Gallyas F, Horváth Z, Buzsáki G. Short-term and long-term changes in the postischemic hippocampus. Annals of the New York Academy of Sciences. 743: 121-39; discussion 1. PMID 7802410 DOI: 10.1111/j.1749-6632.1994.tb55790.x  0.557
1993 Gallyas F, Hsu M, Buzsáki G. Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: 'dark' neurons, perikarya of all neurons, microglial cells and capillaries. Journal of Neuroscience Methods. 50: 159-64. PMID 8107497 DOI: 10.1016/0165-0270(93)90004-B  0.581
1992 Gallyas F, Zoltay G, Dames W. Formation of "dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis). Acta Neuropathologica. 83: 504-9. PMID 1621506 DOI: 10.1007/Bf00310027  0.371
1992 Gallyas F, Hsu M, Buzsaki G. Delayed degeneration of the optic tract and neurons in the superior colliculus after forebrain ischemia. Neuroscience Letters. 144: 177-9. PMID 1436699 DOI: 10.1016/0304-3940(92)90744-R  0.571
1992 Gallyas F, Zoltay G, Horváth Z. Light microscopic response of neuronal somata, dendrites and axons to post-mortem concussive head injury. Acta Neuropathologica. 83: 499-503. PMID 1377858 DOI: 10.1007/Bf00310026  0.333
1992 Gallyas F, Zoltay G, Balás I. An immediate light microscopic response of neuronal somata, dendrites and axons to contusing concussive head injury in the rat. Acta Neuropathologica. 83: 394-401. PMID 1374205 DOI: 10.1007/Bf00713531  0.366
1992 Satoh J, Gallyas F, Endoh M, Yamamura T, Kunishita T, Kobayashi T, Tabira T. Establishment of mouse-immortalized hybrid clones expressing characteristics of differentiated neurons derived from the cerebellar and brain stem regions. Journal of Neurobiology. 23: 905-19. PMID 1359006 DOI: 10.1002/Neu.480230711  0.353
1992 Satoh J, Gallyas F, Endoh M, Yamamura T, Kunishita T, Tabira T. Coexistence of cholinergic, catecholaminergic, serotonergic, and glutamatergic neurotransmitter markers in mouse clonal hybrid neurons derived from the septal region. Journal of Neuroscience Research. 32: 127-37. PMID 1357185 DOI: 10.1002/Jnr.490320202  0.359
1991 Gallyas F, Satoh J, Takeuchi AM, Konishi Y, Kunishita T, Tabira T. Free amino acid- and “monoamine”-content of immortalized neuronal cell lines Neuroscience Research Supplements. 16: 24. DOI: 10.1016/0921-8696(91)90709-V  0.306
1990 Gallyas F, Güldner FH, Zoltay G, Wolff JR. Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology. Acta Neuropathologica. 79: 620-8. PMID 1694382 DOI: 10.1007/Bf00294239  0.376
1990 van den Pol AN, Gallyas F. Trauma-induced Golgi-like staining of neurons: a new approach to neuronal organization and response to injury. The Journal of Comparative Neurology. 296: 654-73. PMID 1694192 DOI: 10.1002/Cne.902960410  0.364
1982 Liposits Z, Görcs T, Gallyas F, Kosaras B, Sétáló G. Improvement of the electron microscopic detection of peroxidase activity by means of the silver intensification of the diaminobenzidine reaction in the rat nervous system. Neuroscience Letters. 31: 7-11. PMID 6750453 DOI: 10.1016/0304-3940(82)90045-3  0.325
Show low-probability matches.